Item 5.07.
|
Submission of Matters to a Vote of Security Holders.
|
Nxt-ID, Inc. (the “Company”)
reconvened its 2019 Annual Meeting of Shareholders (the “Annual Meeting”) on January 17, 2020. Proposals 1 and 2 were
voted on at the Annual Meeting that was originally convened on December 17, 2019 and subsequently adjourned. The final results
for each of the matters submitted to a vote of stockholders at the Annual Meeting, as set forth in the Definitive Proxy Statement,
filed with the Securities and Exchange Commission on October 29, 2019 (the “Proxy Statement”), as supplemented, are
as follows:
On the record date for the Annual Meeting,
there were 29,720,134 shares of Company common stock, $0.0001 par value per share (the “Common Stock”), and 2,000
shares of Series C Non-Convertible Voting Preferred Stock, $0.0001 par value per share, issued, outstanding and entitled to vote.
Stockholders holding 22,085,196 shares of Common Stock were present at the Annual Meeting, in person or represented by proxy.
Proposal 1 – The five nominees
named in the Definitive Proxy Statement were elected to serve as directors for a one-year term expiring at the Company’s
2020 Annual Meeting of Shareholders. The voting results with respect to each nominee were as follows:
Director
|
|
For
|
|
Withheld
|
|
Broker Non-Votes
|
Vincent S. Miceli
|
|
11,034,121
|
|
1,056,662
|
|
12,090,783
|
Major General David R. Gust, USA, Ret.
|
|
10,399,056
|
|
1,691,727
|
|
12,090,783
|
Michael J. D’Almada-Remedios, PhD
|
|
10,782,743
|
|
1,308,040
|
|
12,090,783
|
Daniel P. Sharkey
|
|
10,399,428
|
|
1,751,355
|
|
12,090,783
|
Robert A. Curtis Pharm.D.
|
|
10,602,271
|
|
1,488,512
|
|
12,090,783
|
Michael J. Orlando
|
|
9,218,729
|
|
2,872,054
|
|
12,090,783
|
Proposal 2 – The appointment
of Marcum LLP as the independent registered public accounting firm of the Company for the fiscal year ending December 31, 2019
was ratified by the affirmative vote of a majority of the shares outstanding and entitled to vote on the matter. The voting results
were as follows:
For
|
|
Against
|
|
Abstain
|
20,343,412
|
|
1,344,766
|
|
397,018
|
There were no broker non-votes for Proposal
2.
Proposal 3 – Authorization for
the Board of Directors of the Company (the “Board”) to amend the Company’s Certificate of Incorporation, as
amended, to effect a reverse stock split of all of the Company’s outstanding shares of Common Stock by a ratio in the range
of one-for-three to one-for-fifteen, at any time before May 18, 2020, with such range and timing to be left to the complete discretion
of the Board. The Stockholders approved Proposal 3. The voting results were as follows:
For
|
|
Against
|
|
Abstain
|
15,068,773
|
|
6,705,329
|
|
524,373
|
There were 177,486 broker non-votes for Proposal 3.
Proposal 4 – Ratification of
the Company’s 2017 Stock Incentive Plan. The Stockholders did not approve Proposal 4. The voting results are as follows:
For
|
|
Against
|
|
Abstain
|
10,772,160
|
|
2,577,844
|
|
782,147
|
There were 8,343,810 broker non-votes for
Proposal 4.
Proposal 5 – Ratification of
the approval of the issuance of Common Stock upon conversion of the Exchange Notes (as defined in the Proxy Statement) and exercise
of the Exchange Warrants (as defined in the Proxy Statement) in an amount equal to 20% or more of the Company’s outstanding
Common Stock before such issuance. The Stockholders did not approve Proposal 5. The voting results were as follows:
For
|
|
Against
|
|
Abstain
|
11,267,478
|
|
2,145,034
|
|
719,639
|
There were 8,343,810 broker non-votes for Proposal 5.